相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The K+ uptake regulator TrkA controls membrane potential, pH homeostasis and multidrug susceptibility in Mycobacterium smegmatis
Alfredo Castaneda-Garcia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Reduction of Clofazimine by Mycobacterial Type 2 NADH: Quinone Oxidoreductase A PATHWAY FOR THE GENERATION OF BACTERICIDAL LEVELS OF REACTIVE OXYGEN SPECIES
Takahiro Yano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Bacterial membrane lipids in the action of antimicrobial agents
Richard M. Epand et al.
JOURNAL OF PEPTIDE SCIENCE (2011)
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Armand Van Deun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Dry Powder PA-824 Aerosols for Treatment of Tuberculosis in Guinea Pigs
Lucila Garcia-Contreras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria
Gwan-Han Shen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Comparative Study on Genotypic and Phenotypic Second-Line Drug Resistance Testing of Mycobacterium tuberculosis Complex Isolates
Jakko van Ingen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Jose A. Caminero et al.
LANCET INFECTIOUS DISEASES (2010)
Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents
Katherine M. Coyne et al.
AIDS (2009)
Dry Powder Nitroimidazopyran Antibiotic PA-824 Aerosol for Inhalation
Jean C. Sung et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery
Jean C. Sung et al.
PHARMACEUTICAL RESEARCH (2009)
Proposed mechanism of inactivating Escherichia coli O157:H7 by ultra-high pressure in combination with tert-butylhydroquinone
A. S. Malone et al.
JOURNAL OF APPLIED MICROBIOLOGY (2008)
Bacterial Membranes as Predictors of Antimicrobial Potency
Richard M. Epand et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Clofazimine Inhibits Human Kv1.3 Potassium Channel by Perturbing Calcium Oscillation in T Lymphocytes
Yunzhao R. Ren et al.
PLOS ONE (2008)
Preparation and in Vivo evaluation of a dry powder for inhalation of capreomycin
Jennifer Fiegel et al.
PHARMACEUTICAL RESEARCH (2008)
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model
L. Garcia-Contreras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Degradative transport of cationic amphiphilic drugs across phospholipid bilayers
Magdalena Baciu et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2006)
Development, characterization and stabilization of amorphous form of a low Tg drug
Varsha B. Pokharkar et al.
POWDER TECHNOLOGY (2006)
Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis
MC Cholo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus
ELM Bezerra et al.
ARTHRITIS AND RHEUMATISM (2005)
Linezolid for the treatment of multidrug-resistant tuberculosis
J Fortún et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Antimicrobial activities of seven novel tetra methyl piperidine-substituted phenazines against multiple-drug-resistant Gram-positive bacteria
F Huygens et al.
CHEMOTHERAPY (2005)
Anti-staphylococcal activity and mode of action of clofazimine
B Oliva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Programmes and principles in treatment of multidrug-resistant tuberculosis
JS Mukherjee et al.
LANCET (2004)
Improved dissolution of an insoluble drug using a 4-fluid nozzle spray-drying technique
R Chen et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2004)
Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus
AJ O'Neill et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases
MC Bopape et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Efficacy of clofazimine-modified cyclodextrin against Mycobacterium avium complex in human macrophages
II Salem et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Trojan particles: Large porous carriers of nanoparticles for drug delivery
N Tsapis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid
VM Bulatovic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro
HC Steel et al.
APMIS (2002)
Evaluation of solid dispersions of Clofazimine
AS Narang et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2002)
Antimycobacterial action of B4128, a novel tetramethylpiperidyl-substituted phenazine
NM Matlola et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Manufacture and characterization
P O'Hara et al.
PHARMACEUTICAL RESEARCH (2000)
Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection
K Peters et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis
CEJ van Rensburg et al.
CHEMOTHERAPY (2000)
分享论文
